周二，BMO Capital Markets维持对Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX )的"跑赢大市"评级和545.00美元的目标价，较当前469.97美元的价格有16%的上涨空间。根据 InvestingPro ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.C79yHELW.js ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q4 CY2024 results exceeding the market’s revenue expectations, ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results tomorrow afternoon. Here’s what to look for.

Vertex Pharmaceuticals(VRTX.US)周五公布，旗下非鸦片类止痛药Journavx获美国食品药物管理局批准，该股股价最新升6%。公司指，Journavx是美国逾20年来首个 ...

With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...

Vertex (VRTX) stock was trading largely flat post-market after the company released its Q4 earnings report and issued 2025 ...

Stifel Nicolaus analyst Paul Matteis maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

Vertex Pharmaceuticals (VRTX)长期以来一直被称为提供救命囊性纤维化(CF)药物的公司，这一药物创造了数十亿美元的收益。但现在Vertex正在表明，在治疗最常见的健康问题之一——疼痛方面，它也可以改变游戏规则。

In a report released yesterday, Jessica Fye from J.P. Morgan maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with a ...